Roche has announced it has received FDA clearance for its Accu-Chek Combo system for insulin pump therapy, according to a news release.
The Accu-Chek Combo system combines a blood glucose meter with an insulin pump, which are designed to exchange data via Bluetooth technology. The meter allows the user to test blood glucose levels and allows for operating the insulin pump remotely.
"We are very pleased to announce that our new insulin pump system will soon be available for people with diabetes in the United States," said Daniel O' Day, COO Roche Diagnostics, in the release. "With this clearance we are now looking forward to launch the second device in the United States this year, after the successful clearance of the Accu-Chek Nano SmartView system in the first quarter. Both launches represent a significant milestone for our diabetes care business."
The Accu-Chek Combo system has already been launched in several countries, including France, Germany, United Kingdom and Australia.
Roche is headquartered in Basel, Switzerland.
Related Articles on FDA Clearances:
TriReme Medical Receives FDA Clearance for Expanded Sizes of PTA Balloon Catheter
Bausch + Lomb Seeks FDA Approval for Compound to Treat Inflammation Following Cataract Surgery
Medtronic Receives Expanded FDA Clearance for Pillar Palatal Implant System